AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Dec 3, 2015
29828_dirs_2015-12-03_1232dfc8-64e4-43be-82f3-672b3aa62275.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-12-01
Reporting Person: WILSON GAYLE E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-01 | Common Stock | M | 2104 | — | Acquired | 103873 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-01 | Phantom Shares | $0 | M | 2105.8737 | Acquired | Common Stock (2105.8737) | Direct |
Footnotes
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
F2: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
F3: An aggregate of 2105.8737 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 1.8737 was paid out in cash in connection with the conversion into shares of common stock.